NextGen Healthcare, Inc. Announces Preliminary Unaudited Fiscal 2021 Q3 Results and Raises Fiscal 2021 Financial Guidance - Seite 4

The Company’s future period guidance in this release includes adjustments for items not indicative of the Company’s core operations. Such adjustments are generally expected to be of a nature similar to those adjustments applied to the Company’s historic GAAP financial results in the determination of the Company’s non-GAAP diluted earnings per share. Such adjustments, however, may be affected by changes in ongoing assumptions and judgments as to the items that are excluded in the calculation of non-GAAP adjusted net income and adjusted diluted earnings per share, as described in this release. The exact amount and probable significance of these adjustments, including net acquisition costs, impairment of assets, restructuring costs, net securities litigation defense costs, and other non-run-rate expenses, are not currently determinable without unreasonable efforts, but may be significant. These items cannot be reliably quantified or forecasted due to the combination of their historic and expected variability. It is therefore not practicable to reconcile this non-GAAP guidance to the most comparable GAAP measures.

NEXTGEN HEALTHCARE, INC.

NON-GAAP FINANCIAL MEASURES

(Unaudited)

   

RECONCILIATION OF PRELIMINARY NON-GAAP DILUTED EARNINGS PER SHARE

 

 

Three Months Ended
December 31, 2020
Preliminary Estimate

Diluted net income (loss) per share - GAAP

($0.01) to $0.03

Non-GAAP adjustments:

Acquisition costs, net

0.00

Amortization of acquired intangible assets

0.08

Amortization of deferred debt issuance costs

0.00

Impairment of assets

0.03

Restructuring costs

0.00

Securities litigation defense costs and settlement